🇺🇸 FDA
Patent

US 8691511

Hydroxylated 1,2,4-oxadiazole benzoic acid compounds, compositions thereof and their use in bioassays

granted A61KA61K31/4245A61P

Quick answer

US patent 8691511 (Hydroxylated 1,2,4-oxadiazole benzoic acid compounds, compositions thereof and their use in bioassays) held by PTC THERAPEUTICS, INC. expires Mon Apr 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
PTC THERAPEUTICS, INC.
Grant date
Tue Apr 08 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K31/4245, A61P, A61P11/00, A61P25/00